跳至主要内容
临床试验/SLCTR/2023/016
SLCTR/2023/016招募中2 期

A double-blind randomized controlled trial to investigate the effectiveness and safety of Retinyl Palmitate in patients with chronic Achilles tendinopathy.

Regenall (UK)0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • a. Both male and female >=18 years
  • b. Participating in competitive sport
  • c. Confirmed clinical and /or imaging-based (MRI or Grey-scale ultrasound) diagnosis of chronic mid-portion Achilles tendinopathy
  • d. Unable to regularly participate in their sport due to Achilles tendinopathy for the past minimum 3 months but no longer than 6 months

排除标准

  • a.Previous Achilles tendon rupture on the affected side
  • b.Previous Achilles tendon surgery on the affected side
  • c.History of traumatic tears
  • d.Unable or unwilling to adhere to standardised rehabilitation programme
  • e.Previous history of arrythmias
  • f.History of myocardial infarction or unstable angina within the past 12 months
  • g.History of retinopathy
  • h.Participant is already taking Vitamin A supplementation or other retinoid derivatives
  • i.Participant is taking tetracyclines
  • j.Known hereditary thrombophilia (Factor V Leiden, Protein C/ S deficiency, anti-phospholipid or anti-cardiolipin antibodies)
  • k.Use of Vitamin K antagonist (such as Warfarin)
  • l.Hepatic impairment (AST or ALT > 3 x upper limit of normal)
  • m.Renal impairment (eGFR <10ml/ minute)
  • n.History of moderate or severe hypercalcaemia (total albumin-corrected calcium > 3.0mmol/l)
  • o.Active cancer (or recent cancer diagnosis within 6 months of screening)
  • p.History of allergy or intolerance to retinoids
  • q.Previous history of difficult to manage psychiatric disorders or history of suicidal ideation
  • r.Pregnant or breast-feeding (or not willing to use an approved contraceptive method during treatment and for at least 1-month post treatment)
  • s.Current enrolment in another interventional clinical trial
  • t.Unable to tolerate oral medications
  • u.Gastrointestinal problems that may affect oral drug absorption such as fat malabsorption
  • v.Pancreatic disease
  • w.Not able to consume fish oils/ gelatine-containing substances due to religious, cultural, health or other personal reasons

研究者

发起方
Regenall (UK)

相似试验